Project Grant R16EY038629

Award Date 7/1/25
Completion Date 6/30/29
Dollars Obligated $144K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14623, USA
Similar Awards
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports research to understand the development and function of corneal lens-secreting cells in the human eye. The $543,037 award, effective September 1, 2024 through May 31, 2028, will fund investigations into the genetic and molecular mechanisms underlying corneal development and function. Key research objectives include identifying transcription factors and...
This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), aims to investigate the role of small MAF transcription factors and their co-regulators in controlling gene expression and development of the eye lens. The $386,676 award to the University of Delaware will support research to characterize mouse models with genetic knockout of the MAFG, MAFK, and NRF2 genes, and use advanced genomic techniques to identify their direct targets...
The National Eye Institute (NEI) awarded a $884,273 Project Grant under the Vision Research federal grant program (CFDA 93.867) to The Research Foundation For The State University Of New York (RF SUNY) to conduct a nutritional metabolomics study on age-related macular degeneration (AMD) and retinal integrity. The research aims to examine the relationships between metabolomic dietary patterns, individual metabolites, metabolic pathways, and outcomes related to AMD prevalence and incidence,...
The National Eye Institute (NEI), under the Department of Health and Human Services, awarded a $440,806 Project Grant (CFDA 93.867 - Vision Research) to The Research Foundation for the State University of New York (RF SUNY) to study the role of the molecular chaperone p58IPK in retinal neurons under diabetic conditions. The goal is to define the in vivo function of p58IPK in regulating protein and lipid homeostasis through the integrated stress response and lipid glycosylation pathways, and to...
This $148,568 Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), supports research at Emory University to investigate the role of scleral fibroblasts in refractive development and myopia. The primary objectives are to: 1) Identify characteristics of scleral fibroblasts in mouse eyes that undergo normal refractive development versus those exposed to myopic stimuli, and 2) Determine the role of retinoic acid signaling in driving...
The National Eye Institute (NEI), under the U.S. Department of Health and Human Services, awarded a $606,092 Project Grant through the Vision Research program (CFDA 93.867) to The Regents of the University of California, doing business as the University of California, Berkeley (UC Berkeley). The grant, awarded on January 1, 2025, supports a 4-year research project to investigate the development of the preferred retinal locus (PRL) in individuals with central vision loss due to macular diseases...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) will support research to investigate the role of retinal signaling pathways in the development of myopia, or nearsightedness. The $391,250 award to Emory University will fund a 5-year study to quantify changes in on and off retinal pathways in myopic eyes, determine how disrupting the balance between these pathways impacts myopia susceptibility, and evaluate the influence of ambient light levels on this...
The National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), awarded a $300,001 Project Grant to Kineolabs, Inc. in Billerica, MA. The objective of this 1-year grant, which runs from July 1, 2025 to June 30, 2026, is to develop a portable, low-cost line-scan swept-source optical coherence tomography (LS-SS-OCT) imaging system. This system is intended for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye...
The National Eye Institute (NEI) awarded a $862,580 Project Grant under the Vision Research program (CFDA 93.867) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The grant, titled "The Aging Eyes Study: Mitochondrial Dysfunction as a Driver of Age-Related Vision Loss," will run from Sep 30, 2024 to Sep 29, 2026. The project aims to identify the role of mitochondrial function and genetics in the etiology of aging-related eye diseases,...
This Project Grant award, funded by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867), supports a research project focused on understanding genetic and glial support mechanisms in acute and chronic models of photoreceptor degeneration. The total award amount is $385,000.00 over a 4-year period from August 1, 2025 to July 31, 2029. The project, led by researchers at Wayne State University, aims to compare the transcriptional, cellular, and functional...

The National Eye Institute (NEI), under the U.S. Department of Health and Human Services, awarded a $143,569 Project Grant (CFDA 93.867 - Vision Research) to the Rochester Institute of Technology (RIT) to conduct research on the phase boundaries and liquid structure of concentrated eye lens protein mixtures. The key objectives of this 4-year research project (7/1/2025 - 6/30/2029) are to: (1) test predictions of molecular models of gamma crystallin interactions, (2) study how beta crystallin subtypes combine to form quaternary structures, (3) further investigate relationships between molecular features, free energy, light scattering, and liquid structure in crystallin mixtures, and (4) examine the thermodynamics, liquid structure, and phase diagram of controlled, concentrated aqueous mixtures of the three major classes of mammalian lens crystallins. This research aims to provide a sound molecular understanding of the light scattering, phase diagram, and dynamics of concentrated eye lens protein solutions, which is relevant to the underlying causes of cataract disease.

Generated 8/5/25, 5:29 AM